0001213900-21-014110.txt : 20210309 0001213900-21-014110.hdr.sgml : 20210309 20210308210447 ACCESSION NUMBER: 0001213900-21-014110 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210309 DATE AS OF CHANGE: 20210308 EFFECTIVENESS DATE: 20210309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SciSparc Ltd./ADR CENTRAL INDEX KEY: 0001611746 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-391565 FILM NUMBER: 21723828 BUSINESS ADDRESS: STREET 1: 16 ABBA HILLEL ROAD CITY: RAMAT GAN STATE: L3 ZIP: 5250608 BUSINESS PHONE: 972-3-6167055 MAIL ADDRESS: STREET 1: 16 ABBA HILLEL ROAD CITY: RAMAT GAN STATE: L3 ZIP: 5250608 FORMER COMPANY: FORMER CONFORMED NAME: Therapix Biosciences Ltd. DATE OF NAME CHANGE: 20140624 D 1 primary_doc.xml X0708 D LIVE 0001611746 SciSparc Ltd./ADR 20 RAUL WALLENBERG STREET, A TOWER 2ND FLOOR TEL AVIV L3 ISRAEL 6971916 972-3-6167055 ISRAEL NasVax Ltd. Therapix Biosciences Ltd. Other Limited Company true Amitay Weiss 20 Raul Wallenberg Street, A Tower 2nd Floor Tel Aviv L3 ISRAEL 6971916 Executive Officer Director Chief Executive Officer and Director Oz Adler 20 Raul Wallenberg Street, A Tower 2nd Floor Tel Aviv L3 ISRAEL 6971916 Executive Officer Chief Financial Officer Adi Zuloff-Shani 20 Raul Wallenberg Street, A Tower 2nd Floor Tel Aviv L3 ISRAEL 6971916 Executive Officer Chief Technologies Officer Itschak Shrem 20 Raul Wallenberg Street, A Tower 2nd Floor Tel Aviv L3 ISRAEL 6971916 Director Amnon Ben-Shay 20 Raul Wallenberg Street, A Tower 2nd Floor Tel Aviv L3 ISRAEL 6971916 Director Lior Vider 20 Raul Wallenberg Street, A Tower 2nd Floor Tel Aviv L3 ISRAEL 6971916 Director Moshe Revach 20 Raul Wallenberg Street, A Tower 2nd Floor Tel Aviv L3 ISRAEL 6971916 Director Liat Sidi 20 Raul Wallenberg Street, A Tower 2nd Floor Tel Aviv L3 ISRAEL 6971916 Director Alon Dayan 20 Raul Wallenberg Street, A Tower 2nd Floor Tel Aviv L3 ISRAEL 6971916 Director Pharmaceuticals Decline to Disclose 06b false 2021-03-01 false true true false 39988 Aegis Capital Corp. 15007 None None 810 SEVENTH AVENUE 18TH FLOOR NEW YORK NY NEW YORK 10019 CT CONNECTICUT FL FLORIDA IL ILLINOIS NV NEVADA NJ NEW JERSEY NY NEW YORK false 3873031 0 3873031 An additional $4,276,049.12 raised from investors outside the United States. false 18 271012 0 0 false SciSparc Ltd./ADR /s/ Oz Adler Oz Adler Chief Financial Officer 2021-03-08